Duloxetine hydrochloride structure
Duloxetine hydrochloride
In addition, duloxetine recipients experienced
significantly greater increases in their average voiding interval than placebo
recipients (15.0–20.4 versus 1.7–8.5 minutes). The most commonly observed adverse
events associated with duloxetine therapy are nausea, dry mouth, constipation,
decreased appetite, fatigue, somnolence, and increased sweating. As with other
5-HT reuptake inhibitors, duloxetine is contraindicated in patients taking MAO
inhibitors. Additionally, it is contraindicated
Find 88 Related Holders
MOEHS IBERICA SL
United States
United States
API Registration Country
API Active
AJANTA PHARMA LTD
United States
United States
API Registration Country
API Active
SHODHANA LABORATORIES PRIVATE LTD
United States
United States
API Registration Country
API Active
ZHEJIANG YONGTAI PHARMACEUTICAL CO., LTD.
European Union
European Union
API Registration Country
API Active
SHODHANA LABORATORIES LIMITED
European Union
European Union
API Registration Country
API Active
MACLEODS PHARMACEUTICALS LIMITED
European Union
European Union
API Registration Country
API Active
SANECA PHARMACEUTICALS A.S.
European Union
European Union
API Registration Country
API Active
ESTEVE QUIMICA S.A.
European Union
European Union
API Registration Country
API Active
R L FINE CHEM PVT. LTD.
European Union
European Union
API Registration Country
API Active
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
European Union
European Union
API Registration Country
API Active
Recommended Suppliers of Duloxetine hydrochloride
-
Dingwang Technology (Wuhan) Co., Ltd.
CN1 YR
Contact Supplier -
ROYAL PHARM
CN1 YR
Contact Supplier -
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier